Short, Duncan http://orcid.org/0000-0003-1000-7532
Fredericksen, Rob J.
Crane, Heidi M.
Fitzsimmons, Emma
Suri, Shivali
Bacon, Jean
Musten, Alexandra
Gough, Kevin
Ramgopal, Moti
Berry, Jeff
McReynolds, Justin
Kroch, Abigail
Jacobs, Brenda
Hodge, Vince
Korlipara, Divya
Lober, William
Funding for this research was provided by:
viiv healthcare
Article History
Accepted: 9 January 2022
First Online: 22 January 2022
Declarations
:
: DS is an employee of ViiV Healthcare and may own stock in GlaxoSmithKline. HC has received grants from ViiV Healthcare. SS has received grants from the Ontario HIV Treatment Network (OHTN). MR has received personal fees from Gilead, ViiV Healthcare, Janssen, and Merck for speaking engagements and/or consultancies. JBe has received personal fees from Merck, ViiV Healthcare, and Gilead for advisory board participation. BJ is an employee of Midway Immunology and Research Center, which was hired by Midway Specialty Care Center to oversee this project. RF, EF, JBa, AM, KG, JM, AK, VH, DK, and WL have nothing to disclose.
: The study was conducted in full compliance with International Conference on Harmonization Good Clinical Practice Guidelines, the principles of the Declaration of Helsinki, and the laws and regulations of the countries in which the research was conducted. The study was approved by institutional review boards for the participating clinics. Data handling within the PRO system was in accordance with current US privacy and security regulations governing the storage and transmission of protected health information (ExternalRef removed).
: All study participants provided written informed consent.
: Not applicable.